Literature DB >> 2605455

Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen.

D E Wazer1, O F Tercilla, P S Lin, R Schmidt-Ullrich.   

Abstract

Colony-forming ability after exposure to ionizing irradiation was compared for proliferating hormone response MCF-7 breast carcinoma cells and cells whose growth was inhibited by tamoxifen or 17B-estradiol. As compared with controls (Do = 1.20 Gy, n = 3.1), cells in 1 microM or 5 microM tamoxifen were less radiosensitive (Do = 1.20 Gy, n = 7.0; Do = 1.22 Gy, n = 7.0, respectively) with the predominant effect being a widened shoulder on the survival curve. This protective effect could be abolished by co-incubation of 5 microM tamoxifen with 100 nM 17B-estradiol (Do = 1.30 Gy, n = 2.6; Do = 1.20 Gy, n = 2.6, respectively). The decrease in radiosensitivity induced by tamoxifen was similar to that seen when replating of irradiated plateau-phase cultures was delayed for 24 h (Do = 1.30 Gy, n = 6.0). In contrast, when proliferation of MCF-7 cultures was inhibited by 10 microM 17B-estradiol, radiosensitivity was increased with a markedly diminished survival curve shoulder (Do = 1.40 Gy, n = 1.0). Different hormonal manipulations of cycling human breast carcinoma cells may have profound but disparate effects on radiosensitivity such that tamoxifen and estrogens may serve as useful agents with which to study the biochemical mechanisms of repair.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605455     DOI: 10.1259/0007-1285-62-744-1079

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

1.  Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.

Authors:  Kathrin Dellas
Journal:  Breast Care (Basel)       Date:  2011-10-13       Impact factor: 2.860

2.  Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha.

Authors:  Senad Medunjanin; Sönke Weinert; David Poitz; Alexander Schmeisser; Ruth H Strasser; Ruediger C Braun-Dullaeus
Journal:  EMBO Rep       Date:  2010-01-29       Impact factor: 8.807

3.  Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity.

Authors:  D E Wazer; M Joyce; G Solares; R Schmidt-Ullrich
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872

4.  4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro.

Authors:  J N Sarkaria; E M Miller; C J Parker; V C Jordan; R T Mulcahy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study.

Authors:  Guler Yavas; Cagdas Yavas; Hilal Acar; Hatice Toy; Deniz Yuce; Ozlem Ata
Journal:  Support Care Cancer       Date:  2012-09-01       Impact factor: 3.603

Review 6.  Modulating the Radiation Response for Improved Outcomes in Breast Cancer.

Authors:  Andrea M Pesch; Lori J Pierce; Corey W Speers
Journal:  JCO Precis Oncol       Date:  2021-01-25

7.  Biomarkers of radiosensitivity in a-bomb survivors pregnant at the time of bombings in hiroshima and nagasaki.

Authors:  Edward F Miles; Yoshimi Tatsukawa; Sachiyo Funamoto; Naoko Kamada; Eiji Nakashima; Yoshiaki Kodama; Thomas Seed; Yoichiro Kusonoki; Kei Nakachi; Saeko Fujiwara; Masazumi Akahoshi; Kazuo Neriishi
Journal:  ISRN Obstet Gynecol       Date:  2010-09-29

8.  Guggulsterone-mediated enhancement of radiosensitivity in human tumor cell lines.

Authors:  Rajani Choudhuri; William Degraff; Janet Gamson; James B Mitchell; John A Cook
Journal:  Front Oncol       Date:  2011-07-21       Impact factor: 6.244

9.  Letrozole sensitizes breast cancer cells to ionizing radiation.

Authors:  David Azria; Christel Larbouret; Severine Cunat; Mahmut Ozsahin; Sophie Gourgou; Pierre Martineau; Dean B Evans; Gilles Romieu; Pascal Pujol; Andre Pèlegrin
Journal:  Breast Cancer Res       Date:  2004-12-07       Impact factor: 6.466

10.  Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.

Authors:  D Azria; S Gourgou; W J Sozzi; A Zouhair; R O Mirimanoff; A Kramar; C Lemanski; J B Dubois; G Romieu; A Pelegrin; M Ozsahin
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.